Cupid Ltd Q2FY26: Profit Explodes 140%, Condoms Conquer Continents, and Warrants Go Poof!
1. At a Glance
Cupid Ltd — the company that literally makes love profitable — has delivered a show-stopper Q2FY26. With quarterly revenue of ₹90.23 crore (up a scandalous 90.8% YoY) and a net profit of ₹24.12 crore (up a breathtaking 140%), the Nashik-based condom manufacturer seems to be wearing its crown as India’s most “protective” export hero.
At a market cap of ₹8,978 crore and a stock price of ₹334, Cupid is now the FMCG sector’s most romantic multi-bagger — returning 273% in just one year. While the world argues about safe spaces, Cupid’s safe products are making waves in over 105 countries.
As the Bhagavad Gita wisely says: “Action is better than inaction.” — and Cupid has taken that to heart, because while other FMCG companies are still debating innovation, Cupid has quietly added IVD kits, deodorants, and even fragrances to its rather stimulating product lineup.
But the real kicker? 4.4 crore convertible warrants worth ₹288 crore just expired — and Cupid still managed to retain ₹96 crore cash from the issue. Talk about safe handling of capital and latex.
2. Introduction
Once upon a time in Nashik, a humble company started making condoms when the rest of India was too shy to talk about them. Fast-forward to FY26, Cupid Ltd has turned from a niche latex player to an international FMCG love brand, spreading protection, pleasure, and profits across 105 countries.
Cupid isn’t just making condoms anymore — it’s making statements. With WHO/UNFPA certifications under its belt (literally the condom industry’s Oscar), the company’s credibility is so high that even international agencies trust it to keep the world safe.
While Godrej and Dabur fight over who sells better soap, Cupid’s exporting billions of condoms — and laughing all the way to the bank. Their new deodorant line (aptly described as “from love to lust to luxury”) and IVD kits (Pregnancy, HIV, Dengue, Malaria — basically, the whole hospital shelf) show Cupid’s ambition to dominate both pleasure and healthcare.
And yes, they even ventured into fragrances — because if you can’t resist smelling success, you might as well make it a business.
3. Business Model – WTF Do They Even Do?
Cupid Ltd makes products that keep humanity going — safely. Their business is divided primarily into two verticals: Contraceptives (read: condoms, lubricants) and In Vitro Diagnostic (IVD) kits.
Contraceptives (≈92% of FY24 revenue): This is where Cupid makes its real money. Male condoms (480 million capacity) and female condoms (52 million capacity) dominate the portfolio. They even produce 210 million sachets of lubricant jelly — for those who like to play it smooth.
IVD Kits (≈2% revenue): Cupid’s diversification play — covering pregnancy, HIV, malaria, dengue, and even COVID antigen kits.
Others (≈6%): The experimental basket — recently expanded into deodorants and fragrances, because apparently Cupid now wants to smell like success and seduction.
Geographically, Cupid earns more than 90% of its revenue from exports — mainly WHO and UNFPA-backed contracts to Africa, South America, and Southeast Asia.
They’ve even started acquiring land near Mumbai to double their production capacity — male condoms to 1.25 billion pieces and female condoms to 125 million by FY26. Clearly, they’re not just scaling up; they’re scaling passionately.
